explore -WSS

explore

author：comprehensive 2025-09-29 22:37:09 - browse：41176

Humana’s Medicare Advantage enrollees got care in the hospital and physician clinics way more often than the company predicted at the end of 2023, forcing the health insurance giant on Thursday to drastically slash its profit projections for both 2023 and 2024.

Those higher medical costs will wipe away more than $775 million of profit that Humana had expected to bank for 2023. Humana also is “currently assessing the expected impact of emerging utilization trends on its 2024 outlook, which is anticipated to be material if current trends continue,” according to the company’s update to investors.

Humana’s bad news for Wall Street didn’t end there: The company said it appears it only added just 100,000 new Medicare Advantage members from the most recent enrollment period that ended last month — down from estimates that it would enroll anywhere from 325,000 to 435,000 people.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： After decades in use, heart stents finally beat placebo

hotspot

WSS

Medical school prerequisites are outdated

Ventyx halts psoriasis drug development after lackluster trial results

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Weight loss drugs should be covered by insurers, AMA says

Alabama frozen embryo ruling has major implications for IVF clinics

hotspot

explore

knowledge

Novavax promises a turnaround & Lilly roils the obesity market

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

Jerome Adams on the need for new antivirals for Covid

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Guidelines to prevent youth baseball injuries need more muscle

Experimental asthma app from Apple and Anthem shows promise

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

How state and local governments are sidelining science

Drug repurposing or repositioning? The language matters

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

leisure time

Medicare inequities exacerbate Puerto Rico’s health disparities

What health policies could hitch a ride on a spending bill?

Why palliative psychiatry is worth discussing

What health policies could hitch a ride on a spending bill?

Study suggests Covid rebound is far more common with Paxlovid than without

First transplant of an entire human eye performed

focus

hotspot

explore

focus